Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Noven/JDS Sales Force Expected to Launch Stavzor(TM) in 2008
MIAMI--(HSMN NewsFeed)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN ) today announced that the U.S. Food and Drug Administration (FDA) has issued a tentative approval letter related to the New Dr... Biopharmaceuticals, FDANoven Pharmaceuticals, Stavzor, valproic acid (Source: HSMN NewsFeed)
Increased Mortality Among Critically Ill Patients On Antidepressants
Researchers at Beth Israel Deaconess Medical Center, in Boston, and the Massachusetts Institute of Technology in Cambridge, have found that critically ill patients were more likely to die if they were taking the most commonly prescribed antidepressants when they were admitted to the intensive care unit (ICU). The researchers conducted a retrospective study using the electronic medical records of 10,568 patients to look at in-hospital mortality and mortality a year after being admitted to the ICU... (Source: Health News from Medical News Today)
